The 11 references without contexts in paper N. Pogudina L., E. Kosolapov G., F. Kochenkov S., A. Karaulov V., N. Bondarenko L., D. Blinov V., Н. Погудина Л., Е. Косолапов Г., Ф. Коченков С., А. Караулов В., Н. Бондаренко Л., Д. Блинов В. (2017) “Сравнительный анализ минимизации затрат и влияния на бюджет фиксированных комбинаций ингаляционных глюкокортикостероидов и длительно действующих бета-агонистов для лечения астмы // COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA” / spz:neicon:pharmacoeconomics:y:2017:i:2:p:12-21

1
Global Strategy for Asthma Management and Prevention. 2017. URL: www.ginasthma.org. Accessed: 12.04.2017.
(check this in PDF content)
16
Scicchitano R., Aalbers R., Ukena D. et al. Efficacy and safety of budesonide/ formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004; 20: 1403-1418.
(check this in PDF content)
17
Rabe K. F., Atienza T., Magyar P., Larsson P., Jorup C., Lalloo U. G. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006; 368: 744.
(check this in PDF content)
18
Aubier M., Buhl R., Ekstrom T. et al. Comparison of two twicedaily doses of budesonide/formoterol maintenance and reliever therapy. Eur. Respir. J. 2010: 36: 524-530.
(check this in PDF content)
19
Demoly P., Louis R., Soes-Petersen U. et al. Budesonide/ formoterol maintenance and reliever therapy versus conventional best practice. Respir. Med. 2009; 103: 1623-1632.
(check this in PDF content)
20
Vogelmeier C., D’Urzo A., Pauwels R. et al. Budesonide/ formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur. Respir. J. 2005; 26: 819-828.
(check this in PDF content)
21
Stallberg B., Naya I., Ekelund J. et al. Follow-up programme for patients using Symbicort® Turbuhaler® maintenance and reliever therapy in real-world clinical practice. Prim. Care Respir. J. 2013; 22. A11.
(check this in PDF content)
22
Ställberg B., Naya I., Ekelund J., Eckerwall G. Real-life use of budesonide/formoterol in clinical practice: a 12-month followup assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapy. International J of Clinical Pharmacology and Therapeutics. 2015; 53 (6): 447-455.
(check this in PDF content)
23
Patel M., Pichler P., Pritchard A. at al. Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Resp Med. 2013; 1 (1): 32-42.
(check this in PDF content)
24
O’Byrne P. M., Bisgaard H., Godard P. P. et al. Budesonide/ formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005; 171: 129-36.
(check this in PDF content)
25
Fassakhov R. S. Budesonid/formoterol v rezhime SMART v terapii bronkhial’noi astmy: ot vliyaniya na vospalenie do terapii fenotipov. RMZh. 2016; 16: 1059-1064.
(check this in PDF content)